Management

Mr. Grossman was appointed as the Company's President and Chief Executive Officer and to the Board of Directors effective December 8, 2011. Previously, Mr. Grossman served as a Managing Director at Texas Pacific Group ("TPG"), a private equity firm, where he initiated and led the medical device venture investing effort, and also served as a Senior Advisor to the firm's buyout fund. Prior to joining TPG in 2007, Mr. Grossman spent 23 years in a variety of industry operating roles, including as President and Chief Executive Officer of Thoratec Corporation from 1996 to 2006. Prior to joining Thoratec Corporation, Mr. Grossman was a Division President of Major Pharmaceuticals, Inc., from 1992 to 1995, at which time it was sold. From 1988 to 1992, Mr. Grossman served as the Vice President of Sales and Marketing for the Calcitek division of Sulzermedica (formerly Intermedics, Inc.). Prior to 1988, Mr. Grossman held various sales and marketing management positions within the McGaw Laboratories Division of American Hospital Supply Corporation. Mr. Grossman serves on the boards of directors of Thoratec Corporation and several private medical product companies, and previously served on the boards of directors of Intuitive Surgical, Inc. and Kyphon, Inc. Mr. Grossman received a BS in life sciences from The Ohio State University and an MBA from Pepperdine University.

Ms. Brooks joined Conceptus as Vice President, General Counsel and Corporate Secretary in November 2009 and was promoted to Executive Vice President, General Counsel, Secretary and Chief Compliance Officer in February 2010. Prior to joining Conceptus, Ms. Brooks was Senior Vice President and General Counsel for Perlegen Sciences, Inc., a Silicon Valley biotechnology company developing genetic-based diagnostic tests, from November 2007 to November 2009. Prior to her work at Perlegen, Ms. Brooks served as General Counsel for several medical device and life sciences companies, both public and private, including Westmark International, Inc. (a former Squibb company), Access Health, Inc. and Free & Clear, Inc., and for eCommerce companies including GiftCetificates.com, Inc. and eCharge, Inc. Ms. Brooks earned her law degree from Santa Clara University, her Masters of Law in Taxation from Georgetown University, and her M.B.A. degree from the University of Washington, where she also earned a B.A. degree in Comparative Literature and a B.A. degree in English Literature.

Mr. Chung was appointed Chief Commercial Officer and Executive Vice President in August 2012 and leads Conceptus' global commercial sales and marketing strategies. He has more than 20 years of experience building world-class commercial organizations within the field of implantable medical devices. Prior to joining Conceptus, Mr. Chung served as the President and Chief Executive Officer of Mitralis Medical, an early-stage transcatheter mitral valve repair company from 2011 to 2012. Previously, he spent 15 years with Edwards Lifesciences/Baxter Healthcare. From 2008 to 2011, Mr. Chung served as Global Vice President, Commercial Operations, Heart Valve Therapy, and from 2003 to 2008 as Vice President, Sales and Marketing, Heart Valve Therapy. From 1996 to 2003, Mr. Chung held a variety of sales, sales operations and marketing positions for Edwards. Earlier in his career, he held sales positions at Pfizer-Schneider Interventional Cardiology from 1994 to 1996 and Pfizer-Pharmaceuticals Roerig Division from 1991 to 1994. Mr. Chung served as a PATRIOT Missile officer in the United States Army from 1988 to 1991 and received a B.S. degree in General Engineering and International Relations at the United States Military Academy at West Point.

Ms. Ciano joined Conceptus as Executive Vice President, Human Resources in March 2012 and leads the Company's worldwide human resources function. Previously Ms. Ciano was Senior Vice President, Human Resources for Affymetrix Inc., a gene chip company, where she directed the strategic planning and administration of the company's 1,100-member workforce worldwide for more than four years. Prior to Affymetrix she was at Novellus Systems, Inc. for six years. As Vice President of Human Resources for three years, she led employee development and training, global compensation, organizational development, and employee relations programs for more than 3,300 employees worldwide. For the prior three years at Novellus she served as Senior Director of Customer Satisfaction. Ms. Ciano also worked for Varian Associates for 20 years in a variety of customer service, marketing and business development positions. Ms. Ciano has a Masters Degree in Psychology from JFK University, an M.B.A. from Santa Clara University and a B.S. in Marketing from San Jose State University.

Mr. Lichtwardt joined Conceptus as Executive Vice President, Treasurer and Chief Financial Officer in November 2003 and was promoted to Executive Vice President, Operations, Treasurer and Chief Financial Officer in April 2008. From 2000 to 2002, he was Executive Vice President, Finance, Chief Financial Officer and Corporate Secretary of Innoventry, Inc., a financial services company. From 1993 to 2000, Mr. Lichtwardt was Vice President, Finance, Chief Financial Officer and Treasurer of Ocular Sciences, Inc., a worldwide developer and marketer of soft contact lenses. Prior to his employment with Ocular Sciences, Mr. Lichtwardt, from 1989 to 1993, held senior management positions in various divisions of Allergan Inc. Mr. Lichtwardt currently serves on the Board of Directors of Biolase Technology, Inc., a public medical and dental laser products company, where he also participates on the Audit, Compensation and Quality Compliance Committees. In addition to these positions, Mr. Lichtwardt has held various financial positions at AST Research, Inc. and at divisions of American Hospital Supply Corporation. He earned a B.B.A. degree from the University of Michigan and an M.B.A. degree from Michigan State University.

Dr. Ozdil brings to Conceptus 19 years of medical device experience that spans new product research, development, and commercialization, program management, business development, and intellectual property management. He is responsible for leading the Company's ongoing research and development efforts, which will include improvements to the Essure procedure. Dr. Ozdil has held various executive, management, and engineering positions for both large and small medical device companies including Nanovasc, Angioscore, Medtronic Cardiovascular, Arterial Vascular Engineering, and Baxter Althin Medical. His accomplishments include the development and successful launch of more than 20 cardiovascular devices such as Class III stents and catheters for the treatment of coronary and peripheral artery diseases. Dr. Ozdil has also held several director-level positions at Medtronic Cardiovascular, where his work included building and leading teams for the invention and development of new advanced products integrating biotechnology onto device platforms, including drug-eluting metallic and biodegradable stents.

Mr. Sharpe joined Conceptus as the Executive Vice President of Operations in January 2013. Mr. Sharpe has 25 years of experience in the medical device field. Before joining the Company, Mr. Sharpe served as the Senior Vice President of Operations at Optovue, Inc., from September 2010 to January 2013. Before that, Mr. Sharpe served as Vice President of Operations at Thoratec Corporation from 1997 to 2006. Prior to his tenure at Thoratec Corporation, Mr. Sharpe held numerous positions in operations with Baxter Healthcare Corporation from 1983 to 1997, with increasing scale and responsibility culminating in his role as Director of Operations from 1992 to 1997. Mr. Sharpe received a B.S. degree in mechanical engineering from the University of Massachusetts at Lowell.

Mr. Yu was named Vice President of Regulatory, Clinical and Medical Affairs at Conceptus in September 2009. In this role, he oversees the company's medical affairs and global clinical research activities, and regulatory affairs efforts. Mr. Yu joined Conceptus in July 2006 and most recently served as Senior Director of Clinical Research and Regulatory Affairs. From 2003 to 2006, he was responsible for the regulatory affairs strategies supporting new ventures and research and technology programs at Guidant Vascular Intervention, which became a part of Abbott Laboratories through its 2006 acquisition of Guidant VI. Before joining Guidant, Mr. Yu held positions in regulatory affairs, marketing, finance and manufacturing at diverse healthcare companies including Durect Corp., Lumenis, Inc., Lifescan, Inc., Roche Bioscience, and Genentech. He holds a B.S. degree from the University of California at Davis, and an M.B.A. degree from Santa Clara University.